» Articles » PMID: 24138782

Antibacterial Effects of Apis Mellifera and Stingless Bees Honeys on Susceptible and Resistant Strains of Escherichia Coli, Staphylococcus Aureus and Klebsiella Pneumoniae in Gondar, Northwest Ethiopia

Overview
Publisher Biomed Central
Date 2013 Oct 22
PMID 24138782
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Honey is a natural substance produced by honeybees and has nutritional and therapeutic uses. In Ethiopia, honeys are used traditionally to treat wounds, respiratory infections and diarrhoea. Recent increase of drug resistant bacteria against the existing antibiotics forced investigators to search for alternative natural remedies and evaluate their potential use on scientific bases. Thus, the aim of this study was to evaluate the antibacterial effects of different types of honeys in Ethiopia which are used traditionally to treat different types of respiratory and gastrointestinal infections.

Methods: Mueller Hinton agar (70191) diffusion and nutrient broth culture medium assays were performed to determine susceptibility of Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922) and resistant clinical isolates (Methicillin resistant Staphylococcus aureus(MRSA), Escherichia coli(R) and Klebsiella pneumoniae (R), using honeys of Apis mellifera and stingless bees in northern and north western Ethiopia.

Results: Honey of the stingless bees produced the highest mean inhibition (22.27 ± 3.79 mm) compared to white honey (21.0 ± 2.7 mm) and yellow honey (18.0 ± 2.3 mm) at 50% (v/v) concentration on all the standard and resistant strains. Stingless bees honey was found to have Minimum Inhibitory Concentration (MIC) of 6.25% (6.25 mg/ml) for 80% of the test organisms compared to 40% for white and yellow Apis mellifera honeys. All the honeys were found to have minimum bactericidal concentration (MBC) of 12.5% (12.5 mg/ml) against all the test organisms. Staphylococcus aureus (ATCC 25923) was susceptible to amoxicillin, methicillin, kanamycine, tetracycline, and vancomycine standard antibiotic discs used for susceptibility tests. Similarly, Escherichia coli (ATCC 25922) was found susceptible for kanamycine, tetracycline and vancomycine. Escherichia coli (ATCC 25922) has not been tested for amoxicillin ampicillin and methicillin. The susceptibility tests performed against Staphylococcus aureus (MRSA), Escherichia coli (R) and Klebsiella pneumoniae (R) using three of methicillin, erythromycin, ampicillin, Penicillin and amoxicillin discs were resistant. But, these drug resistant strains were susceptible to antibacterial agents found in the honeys and inhibited from 16 mm to 20.33 mm.

Conclusions: Honeys in Ethiopia can be used as therapeutic agents for drug resistant bacteria after pharmaceutical standardization and clinical trials.

Citing Articles

Profile of stingless bee honey and microbiota produced in West Sumatra, Indonesia, by several species ().

Melia S, Juliyarsi I, Kurnia Y, Aritonang S, Rusdimansyah R, Sukma A Vet World. 2024; 17(4):785-795.

PMID: 38798299 PMC: 11111726. DOI: 10.14202/vetworld.2024.785-795.


Stingless bee honey: Nutritional, physicochemical, phytochemical and antibacterial validation properties against wound bacterial isolates.

Mwangi M, Wanjau T, Omwenga E PLoS One. 2024; 19(5):e0301201.

PMID: 38743750 PMC: 11093306. DOI: 10.1371/journal.pone.0301201.


Comprehensive analysis of the microbiome in honey highlights honey as a potential source for the isolation of beneficial bacterial strains.

Lanh P, Duong B, Thu H, Hoa N, Quyen D PeerJ. 2024; 12:e17157.

PMID: 38560453 PMC: 10981410. DOI: 10.7717/peerj.17157.


Antioxidants Discovery for Differentiation of Monofloral Stingless Bee Honeys Using Ambient Mass Spectrometry and Metabolomics Approaches.

Chuah W, Lee H, Ng D, Ho A, Sulaiman M, Chye F Foods. 2023; 12(12).

PMID: 37372615 PMC: 10297175. DOI: 10.3390/foods12122404.


Assessing the Antimicrobial Properties of Honey Protein Components through In Silico Comparative Peptide Composition and Distribution Analysis.

Lyskowski A, Milek M, Dzugan M Antibiotics (Basel). 2023; 12(5).

PMID: 37237732 PMC: 10215533. DOI: 10.3390/antibiotics12050830.


References
1.
Namias N . Honey in the management of infections. Surg Infect (Larchmt). 2003; 4(2):219-26. DOI: 10.1089/109629603766957022. View

2.
Tanih N, Dube C, Green E, Mkwetshana N, Clarke A, Ndip L . An African perspective on Helicobacter pylori: prevalence of human infection, drug resistance, and alternative approaches to treatment. Ann Trop Med Parasitol. 2009; 103(3):189-204. DOI: 10.1179/136485909X398311. View

3.
Gheldof N, Wang X, Engeseth N . Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem. 2002; 50(21):5870-7. DOI: 10.1021/jf0256135. View

4.
Temaru E, Shimura S, Amano K, Karasawa T . Antibacterial activity of honey from stingless honeybees (Hymenoptera; Apidae; Meliponinae). Pol J Microbiol. 2008; 56(4):281-5. View

5.
Fahey J, Stephenson K . Pinostrobin from honey and Thai ginger (Boesenbergia pandurata): a potent flavonoid inducer of mammalian phase 2 chemoprotective and antioxidant enzymes. J Agric Food Chem. 2002; 50(25):7472-6. DOI: 10.1021/jf025692k. View